Middle East Pharmaceutical Industries Co. (4016)

• Stock
• Company Profile
• News
• Announcements
• Fair Values
• Corporate Actions
• Earning Announcements
• News Reports
• Major Shareholders
• Volume Statistics
• Financial Ratios
• IPOs
• Financial Statements
• Support and resistance
• More

General Information

Company Name Middle East Pharmaceutical Industries Co. (4016)

Company Purpose Middle East Pharmaceutical Industries Co. (known as: AVALON PHARMA) is a public company, listed on Saudi Exchange “Tadawul” (TDWL) since Februry 2024. AVALON PHARMA operats within the pharmaceuticals Research and Biotechnology Sector focusing on Pharmaceuticals and Biotechnology Research & Development. AVALON PHARMA is Based in Riyadh, Saudi Arabia and was Established in June 1998.

Company Establish Date 29 June 1998

Financial Year Start

Auditor

• Ernst and Young and Co. Certified Public Accountants

Ownership

• Tabbaa National Holding Co (42.175%)
• Talal Youssef Mahmoud Zahid (14.70%)

Management

Ahmed Shaher Ahmed Altabbaa Chairman

Hisham Mohammed Mahmoud Attar Deputy Chairman

Mohammed Maher Mohammed Lotfi Al Ghannam Managing director

Omar Al Jaroudi Board Members

Faisal Sulaiman Mohamed Aljaman Board Members

Subsidiaries

• Avalon Pharma UK Holdings Ltd (100.00%)

Contacts

Address Second Industrial City, PO Box 3800, Riyadh 14331, Kingdom of Saudi Arabia

Phone +966 11 2653948

Fax +966 11 2654723

Website www.avalonpharmaceutical.com

Email investor.relations@avalon.com.sa

Contact Person